neurodegenerative disease

Exercise-induced molecules may inspire the next generation of neuroprotective drugs.

Many potential treatments for Alzheimer’s disease have been found using mouse models, but they often don’t translate well to humans. Will organoids provide the answers that neuroscientists need to develop new treatments?

Entomologists and computer engineers developed a novel imaging method for analyzing gene expression in live brains.

Membraneless droplet like organelles known as condensates are changing the way some scientists approach drug discovery.

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

Researchers built a framework to purposefully identify drug candidates for repurposing.

By fusing a brain-targeted antibody with an antibody that protects neurons from degeneration, scientists developed a new class of drugs that can traverse the blood brain barrier, enabling potential new treatments for Parkinson’s disease, Alzheimer’s disease, and depression.